5090792026-11-055090792026-11-05in-capmkt:StageOfTheLitigationIsConcludedOrDisputeIsResolvedMember5090792026-11-05in-capmkt:ChangeInStatusMemberGUFICBIOGufic Biosciences Limited509079NOTLISTEDINE742B01025Pendency of any litigation(s) or dispute(s) (Sub-para 8-Para B)Regularly till the litigation is concluded or dispute is resolvedNewfalse2026-11-0411:24:002026-11-05Change in statusPursuant to the Assessment Order dated March 18, 2025, a tax demand of Rs. 11,88,88,580/- was raised against the Company, which was subsequently reduced to Rs. 11,76,198/- by the Commissioner of Income Tax (Appeals) [“CIT(A)”]. The Income Tax Department filed an appeal before the ITAT against the relief granted by the CIT(A), while the Company filed a cross-objection against the disallowance sustained by the CIT(A). By the order dated October 15, 2026, passed by the Hon’ble Income Tax Appellate Tribunal (ITAT), Mumbai, the ITAT has allowed both the Department’s appeal and the Company’s cross-objection for statistical purposes, set aside the findings of the CIT(A), and restored the matters to the file of the Assessing Officer for fresh consideration in accordance with law. The tax liability, if any, will be determined upon completion of the fresh assessment proceedings.2025-03-19The ITAT has allowed both the Department’s appeal and the Company’s cross-objection for statistical purposes and set aside the findings of the CIT(A) and restored the matters to the file of the Assessing Officer for fresh consideration in accordance with law.Company